AI-generated summary
In a rat model of acute osteoarthritis induced with papain, the authors studied whether photobiomodulation therapy at 808 nm affected inflammatory markers and pain-related measures at 6, 24, and 48 hours. They report that the therapy was associated with reduced TNF-α, CINC-1 and bradykinin receptor expression, and higher pressure pain thresholds. The study is in animals, so applicability to humans is not established.
- Participants
- 54
- Who or what was studied
- Rats with papain-induced acute osteoarthritis (54 rats divided into control, OA and OA PBMT groups)
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The study used an experimental animal model, and the abstract does not describe a human population or report human outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Energy density (fluence)
- 144 J/cm2
- Power
- 50 mW
- Total energy
- 4 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Osteoarthritis, Photobiomodulation, Wavelength, Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.